Skip to content

Absci Corporation ABSI Available-for-Sale Debt Securities - Amortized Cost

Available-for-Sale Debt Securities - Amortized Cost at other companies

Precigen logo
PrecigenPGEN
$49.27M-34.2%
Zymeworks logo
ZymeworksZYME
$120.41M-36.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$695.19M+281%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$607.54M+349%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's available-for-sale debt securities - amortized cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's available-for-sale debt securities - amortized cost?
Absci Corporation (ABSI) reported available-for-sale debt securities - amortized cost of $122.78M in Q1 2026.
How has Absci Corporation's available-for-sale debt securities - amortized cost changed year-over-year?
Absci Corporation's available-for-sale debt securities - amortized cost increased by 41.1% year-over-year, from $86.98M to $122.78M.
What is the long-term trend for Absci Corporation's available-for-sale debt securities - amortized cost?
Over 3 years (2022 to 2025), Absci Corporation's available-for-sale debt securities - amortized cost has grown at a 8.1% compound annual growth rate (CAGR), from $109.57M to $138.47M.
What does available-for-sale debt securities - amortized cost mean?
This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or discounts. It represents the value of the investment portfolio before accounting for current market price fluctuations. This provides a baseline for evaluating the performance of the company's liquid investment strategy.